Parkinson's progression equates to increased drug costs

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.504, 2006-01, pp. : 7-7

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment Benefit and Daily Drug Costs Associated with Treating Parkinsons Disease in a Parkinsons Disease Clinic

By Müller T.

CNS Drugs, Vol. 18, Iss. 2, 2004-01 ,pp. : 105-111

Adis International

Access to resources Recommend Favorite

Levodopa/carbidopa and Parkinson's disease progression

Inpharma, Vol. 1, Iss. 1468, 2004-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Cancer drug costs discussed

Inpharma, Vol. 1, Iss. 1460, 2004-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Motor complications, levodopa metabolism and progression of Parkinson's disease

By Müüller Thomas

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 7, 2011-07 ,pp. : 847-855

Informa Healthcare

Access to resources Recommend Favorite

Ubidecarenone may slow progression of Parkinson's disease

Inpharma, Vol. 1, Iss. 1361, 2002-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite